Pablo Martinez-Pena

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Journal: Nature communications
Published: April 10, 2025

Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment.

Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment.

Journal: Journal for immunotherapy of cancer
Published: November 12, 2024

Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells.

Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells.

Journal: PloS one
Published: July 08, 2024

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Journal: Nature cancer
Published: January 19, 2024

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Journal: Blood
Published: July 10, 2023

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Journal: Blood advances
Published: February 09, 2023

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

Journal: Blood advances
Published: March 25, 2022

Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia.

Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia.

Journal: Genes, chromosomes & cancer
Published: October 19, 2020

Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation.

Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation.

Journal: Haematologica
Published: August 25, 2020

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

Journal: Cell reports
Published: October 25, 2019

Clonal competition within complex evolutionary hierarchies shapes AML over time.

Clonal competition within complex evolutionary hierarchies shapes AML over time.

Journal: Nature communications
Published: March 27, 2019

Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.

Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.

Journal: Haematologica
Published: February 27, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026